Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics
November 21, 2024 04:06 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Congenital Adrenal Hyperplasia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
October 31, 2024 08:00 ET
|
Mangoceuticals, Inc.
Dallas, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness...
Hormone Replacement Therapy (HRT) Market Insights, Competitive Landscape, and Forecast to 2030: Surging Demand for Advanced Drug Delivery Systems Such as Transdermal drugs with Greater Efficacy
October 22, 2024 10:13 ET
|
Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Hormone Replacement Therapy (HRT) Market to Surpass $30 Billion by 2029 - Oral HRT is the Preferred Choice for Convenience and Compliance
June 13, 2024 04:04 ET
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Hormone Replacement Therapy Market Outlook, 2029" report has been added to ResearchAndMarkets.com's offering. The Global Hormone Replacement...
North America Hormone Replacement Therapy (HRT) Market Research 2024: A $6.9 Billion Industry by 2032, Driven by New Treatment Options and Increasing R&D to Enhance Quality and Efficiency
May 31, 2024 04:14 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "North America Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Country 2024-2032" report has been...
United States Sex Reassignment Hormone Therapy Research Report 2024 Featuring Viatris, AbbVie, ASCEND Therapeutics, Pfizer, Eli Lilly and Co, Novartis, Endo International
May 30, 2024 04:13 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "United States Sex Reassignment Hormone Therapy Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ...
Global Hormone Replacement Therapy Research Report 2024: A $35+ Billion Market by 2032 - Industry Trends, Share, Growth, Insight, Top Companies
May 24, 2024 07:48 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Hormone Replacement Therapy Market, Size, Forecast 2024-2032, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies...
Hypoparathyroidism Market Insight, Epidemiology And Market Forecast to 2032
May 17, 2024 04:01 ET
|
Research and Markets
Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "Hypoparathyroidism - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global...
5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028
April 15, 2024 09:19 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "5-Alpha Reductase Deficiency Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The 5-alpha reductase deficiency market...
Synthetic Hormones Market Analysis Report 2023-2033, Featuring Profiles of Eli Lilly, Pfizer, Ferring, Merck, Novo Nordisk, Bayer, Novartis and More
November 27, 2023 04:28 ET
|
Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Synthetic Hormones Market: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape - Analysis...